SPY382.88-1.36 -0.35%
DIA309.97-1.90 -0.61%
IXIC13,543.06+12.15 0.09%

Mizuho Initiates Coverage On AbbVie with Buy Rating, Announces $96 Price Target

Mizuho analyst Vamil Divan initiates coverage on AbbVie (NYSE:ABBV) with a Buy rating and a $96 price target.

Benzinga · 02/06/2020 10:10

Mizuho analyst Vamil Divan initiates coverage on AbbVie (NYSE:ABBV) with a Buy rating and a $96 price target.